AngioDynamics
AngioDynamics Appoints Eric Honroth President and Chief Executive Officer
AngioDynamics announced a leadership change on October 8, 2026. AngioDynamics announced that Eric Honroth, who most recently served as Global President, Life Science at Getinge, will become President and CEO on November 2, 2026, succeeding Jim Clemmer, who is retiring after ten years in the role.
What changed
Eric Honroth was named President and Chief Executive Officer. Jim Clemmer, who is retiring after ten years as President and Chief Executive Officer, will depart the Board on November 2, 2026, and will remain in a consulting capacity to ensure a smooth transition.
- Leader: Eric Honroth
- Role: President and Chief Executive Officer
- Effective: November 2, 2026
- Announcement date: October 8, 2026
Leadership background
Honroth has more than 20 years of medical device and life sciences leadership experience, with earlier senior leadership roles at Abbott Vascular, Becton Dickinson, CareFusion, and Boston Scientific. Most recently he served as Global President, Life Science at Getinge, and previously led Getinge’s $1.2 billion North American business.
The mandate
AngioDynamics said its Board-led search prioritized a leader with medical technology experience to build on the company’s Med Tech momentum and drive sustainable revenue growth, margin expansion, and long-term shareholder value.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: AngioDynamics leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


